Ideas for change: Why the drugs don’t work
Twenty per cent of medical advice is incorrect — for the simple reason that we all have a different genetic make-up. The number of patients who do not respond to first-time drugs for almost all diseases is high — up to 70% for Alzheimer’s or cancer patients; and this high failure rate is bad for patients and expensive for healthcare systems.
Oz recognizes that we can have more efficient, better value medicine if we personalize medical intervention based on an individual’s genome; this facilitates identification and early intervention for those at risk of chronic diseases, delaying the onset and minimizing the effects of the illness. The battle over healthcare costs will not be won in the heart of government — it will be won by personalizing medical services.
Author: Mehmet Oz is well known for his numerous television appearances, articles and books, including a regular slot on Oprah. His approach to health and well-being advocates the incorporation of both traditional Western techniques for treating disease and alternative ideas about healthy lifestyle choices to achieve overall wellness.
A graduate of Harvard, Wharton and the University of Pennsylvania, Oz is Vice-Chair of Surgery and Professor of Cardiac Surgery at Columbia University. He directs the Cardiovascular Institute and is a Founder and Director of the Complementary Medicine Program at New York Presbyterian Medical Center.
Image: Between as much as 40% and 70% of first time prescriptions fail because we all have different genetic make-up.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Forum Stories newsletter
Bringing you weekly curated insights and analysis on the global issues that matter.